Nanograb
YC S23 · Active · Deliver genes to any cell with AI
Competitors
| Company | Category | Status | Program |
|---|---|---|---|
| Other | Active | YCW18 | |
| Other | Acquired | YCW22 | |
| Other | Active | YCW21 | |
| AI | Active | YCW15 | |
| AI | Active | YCW22 |
Adjacent
| Company | Category | Status | Program |
|---|---|---|---|
| Other | Inactive | YCW20 | |
| Other | Public | YCS20 | |
| AI | Active | YCS25 | |
| AI | Active | YCS21 | |
| Other | Active | YCW18 |
Also from S23 in AI
All of S23About Nanograb
Nanograb is a computational drug discovery company that uses AI to create novel targeted non-viral gene therapy vectors. Our platform designs unique combinations of small peptide binders attached to nanoparticles to safely deliver genetic medicines to specific cells and tissues in the body at scale.
- YC batch
- S23 · Summer 2023
- Status, per YC
- Active
- Category
- AI
- Team size
- 5
- Location
- London, England, United Kingdom
- Checked
- 33m ago
YC tags: AI-powered Drug Discovery, Nanomedicine, Biotech, Drug Delivery, Therapeutics
Nanograb: questions
Which YC batch was Nanograb in?
Nanograb was in Y Combinator's Summer 2023 batch (S23).
Is Nanograb still active?
Y Combinator lists Nanograb as active.
Where is Nanograb based?
Nanograb lists London, England, United Kingdom as its location on YC's directory.
Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.